Author

A J Scheen

Observed names: Andr?? J Scheen, Andr?? J. Scheen

Institutions: University of Liège, Centre Hospitalier Universitaire de Liège

Observed institutions: University of Liège, Centre Hospitalier Universitaire de Liège

OpenAlex ID: A5111409667

Prevention of Type 2 Diabetes Mellitus Through Inhibition of the Renin-Angiotensin System

2004 · Andr?? J Scheen · Drugs · 294

Is There a Role for ??-Glucosidase Inhibitors in the Prevention of Type 2 Diabetes Mellitus?

2003 · Andr?? J Scheen · Drugs · 244

Drug Interactions of Clinical Importance with Antihyperglycaemic Agents: An Update

2005 · Andr?? J Scheen · Drug Safety · 148

Hepatotoxicity with Thiazolidinediones: Is it a Class Effect?

2001 · Andr?? J. Scheen · Drug Safety · 142

Lipodystrophy Reactions to Insulin: Effects of Continuous Insulin Infusion and New Insulin Analogs

2007 · R??gis P Radermecker, G??rald E Pi??rard, et al. · American Journal of Clinical Dermatology · 109

Drug-Drug and Food-Drug Pharmacokinetic Interactions with New Insulinotropic Agents Repaglinide and Nateglinide

2007 · Andr?? J Scheen · Clinical Pharmacokinetics · 81

Combined Thiazolidinedione-Insulin Therapy: Should We Be Concerned About Safety?

2004 · Andr?? J Scheen · Drug Safety · 73

Pharmacokinetic Interactions with Thiazolidinediones

2007 · Andr?? J Scheen · Clinical Pharmacokinetics · 65

Tolerability Profile of Metformin/Glibenclamide Combination Tablets (Glucovance??): A New Treatment for the Management of Type 2 Diabetes Mellitus

2004 · Jaime A Davidson, Andr?? J Scheen, et al. · Drug Safety · 20

Metformin Extended Release: A Viewpoint by Andr?? J. Scheen

2006 · Andr?? J Scheen · American Journal of Drug Delivery

Works count: 10

Citation count: 1,176

H-index: 9

I10-index: 9